1. 535TiPPhase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study). (24th November 2019) Authors: Ikeda, S; Kato, T; Kenmotsu, H; Ogura, T; Iwasawa, S; Iwasawa, T; Kasajima, R; Miyagi, Y; Misumi, T; Yamanaka, T; Okamoto, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy. Issue 1 (December 2015) Authors: Makino, S; Kita, H; Miyatake, Y; Yokoyama, T; Kubota, K; Obata, N; Egi, M; Misumi, T; Izuta, S; Mizobuchi, S Journal: Critical care Issue: Volume 19:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗